Technology
Health
Biotechnology
Summit Therapeutics
$1.929876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.92
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.01 (-0.47%) Today
-$0.01 (-0.47%) Today
Why Robinhood?
You can buy or sell SMMT and other stocks, options, ETFs, and crypto commission-free!
About
Summit Therapeutics plc American Depositary Shares, also called Summit Therapeutics, is a holding company, which engages in the discovery, development, and commercialization of novel medicines. It focuses on the genetic disease duchenne muscular dystrophy, and the infectious disease clostridium difficile infection. Read More The company was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, United Kingdom.
Employees
76
Headquarters
Abingdon, Oxfordshire
Founded
2004
Market Cap
31.75M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
90.45K
High Today
$1.97
Low Today
$1.90
Open Price
$1.90
Volume
10.39K
52 Week High
$14.29
52 Week Low
$1.10
Collections
Technology
Health
Biotechnology
Therapy
2015 IPO
UK
Europe
News
Markets InsiderFeb 26
6 Top Gainers In Healthcare Sector (SMMT, HTBX, NTGN...)
(RTTNews) - The following are some of today's top gainers in the pharma/biotech sector. 1. Summit Therapeutics plc (SMMT) Gained 28.97% to close Tuesday's (Feb.26) trading at $1.87. News: The Company announced that preclinical data on SMT-571, which is in development for the treatment of gonorrhoea, shows that the compound is potent against diverse, global Neisseria gonorrhoeae strains from actual patient cases, including numerous multi- and extensively-drug resistant strains. Clinical Trials & Near-ter...
Yahoo FinanceFeb 19
New Research Coverage Highlights Global Payments, Tableau Software, Summit Therapeutics, Utah Medical Products, Apollo Commercial Real Estate Finance, and Urstadt Biddle Properties — Consolidated Reve
NEW YORK, Feb. 19, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Global Payments Inc. (GPN), Tableau Software, Inc. (DATA), Summit Therapeutics PLC (SMMT), Utah Medical Products, Inc. (UTMD), Apollo Commercial Real Estate Finance (ARI), and Urstadt Biddle Properties Inc. (UBA), including updated fundamental summaries, consolidated fiscal reporting, and f...
Price Paid on Robinhood
15% Lower
Right Now
52 Week Low
$1.10
Average Price Paid
$2.27
52 Week High
$14.29
Earnings
-$0.53
-$0.21
$0.10
$0.42
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Estimated
—
Actual
—